(S)-tert-Butyl 2-methyl-3-oxoazetidine-1-carboxylate, 97%, 250mg

N-Acetyl-D-methionine, 95.0%, 100g

Ethyl-3-cyclopentenecarboxylic acid, 98.0%, 1g

(2,4,6-Trifluoro-3-hydroxyphenyl)boronic acid, 98%, 1g

(R)-3-(Methoxymethyl)morpholine hydrochloride, 95.0%, 100mg

(5-Chloro-2-(ethoxycarbonyl)phenyl)boronic acid, 95.0%, 5g

N-(1-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-hydroxy-3-methoxytetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)benzamide, 98%, 5g

EDTA disodium salt solution, ROTI® volume 0.1 mol/l - 0.1 N, ampoule, 1 piece

(3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate, 97.0%, 25mg

Ethyl 3-hydroxybutanoate, 95.0%, 25g

Glycine, N-(2,6-dimethylphenyl)-, 97%, 250mg

(Carbethoxymethylene)triphenylphosphorane, 95.0%, 25g

Potassium Cyclopropyltrifluoroborate>95.0%(T)5g